Akinori Morita

Prof. Dr. Akinori Morita

Department of Biomedical Science and Technology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8503, Japan
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Akinori MoritaAkinori Morita
Akinori Morita
KTKeiji Tanimoto
Keiji Tanimoto
TMTomoki Murakami
Tomoki Murakami
TMTakeshi Morinaga
Takeshi Morinaga
YHYoshio Hosoi
Yoshio Hosoi

24 November 2013 in Oncotarget
Verified
Journal Article
Open access
PDF file
Akinori MoritaAkinori Morita
Akinori Morita
SAShinya Ariyasu
Shinya Ariyasu
SOSoichiro Ohya
Soichiro Ohya
ITIppei Takahashi
Ippei Takahashi
BWBing Wang
Bing Wang
YHYoshio Hosoi
Yoshio Hosoi
In a previous study, we reported that sodium orthovanadate (vanadate) is the first known inhibitor that is capable of protecting mice from death from the radiation-induced gastrointestinal syndrome via its ability to block both transcription-dependent and transcription-independent p53 apoptotic pathways. In this paper, we report that vanadate has a unique activity for inducing the denaturation of p53 relative to other known radioprotective p53 inhibitors, pifithrin-α (PFTα) and pifithrin-µ (PFTµ). This potent radioprotective effect of vanadate prompted us to undertake a more extensive search for p53 inhibitors that can induce p53 denaturation. Based on the fact that p53 denaturation can be induced by the dissociation of a zinc ion, which is used as a structural factor of p53, we screened some zinc (II) chelators for the suppression of the DNA binding activity of p53 in vitro and the inhibition of radiation-induced p53-dependent apoptosis in MOLT-4 cells. The findings indicate that two of five zinc (II) chelators also suppressed apoptosis. Among the inhibitors tested, Bispicen (N,N’-Bis(2-pyridylmethyl)-1,2-ethanediamine) had the highest inhibition activity. A mechanistic study using cells bearing different p53 status or functions (i.e., p53-knockdown MOLT-4 transformant and its revertants, p53 mutant cells, p53-null cells), and p53-independent apoptotic stimuli revealed that the suppressive effect of Bispicen on apoptosis is specifically mediated through p53. Moreover, Bispicen, similar to vanadate, induces the denaturation of p53 as well as the blocking of both transcription-dependent and -independent apoptotic pathways. Our findings indicate that the use of zinc (II) chelators represent a new approach for protecting against radiation-induced p53-dependent apoptosis through the inhibition of p53-dependent apoptotic pathways.

1 February 2018 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
Akinori MoritaAkinori Morita
Akinori Morita
ITIppei Takahashi
Ippei Takahashi
MSMegumi Sasatani
Megumi Sasatani
SAShin Aoki
Shin Aoki
BWBing Wang
Bing Wang
TIToshiya Inaba
Toshiya Inaba
Inhibiting p53-dependent apoptosis by inhibitors of p53 is an effective strategy for preventing radiation-induced damage in hematopoietic lineages, while p53 and p21 also play radioprotective roles in the gastrointestinal epithelium. We previously identified some zinc(II) chelators, including 8-quinolinol derivatives, that suppress apoptosis in attempts to discover compounds that target the zinc-binding site in p53. We found that 5-chloro-8-quinolinol (5CHQ) has a unique p53-modulating activity that shifts its transactivation from proapoptotic to protective responses, including enhancing p21 induction and suppressing PUMA induction. This p53-modulating activity also influenced p53 and p53-target gene expression in unirradiated cells without inducing DNA damage. The specificity of 5CHQ for p53 and p21 was demonstrated by silencing the expression of each protein. These effects seem to be attributable to the sequence-specific alteration of p53 DNA-binding, as evaluated by chromatin immunoprecipitation and electrophoretic mobility shift assays. In addition, 5-chloro-8-methoxyquinoline itself had no antiapoptotic activity, indicating that the hydroxyl group at the 8-position is required for its antiapoptotic activity. We applied this remarkable agonistic activity to protecting the hematopoietic and gastrointestinal system in mouse irradiation models. The dose reduction factors of 5CHQ in total-body and abdominally irradiated mice were about 1.2 and 1.3, respectively. 5CHQ effectively protected mouse epithelial stem cells from a lethal dose of abdominal irradiation. Furthermore, the specificity of 5CHQ for p53 in reducing the lethality induced by abdominal irradiation was revealed in Trp53-KO mice. These results indicate that the pharmacologic upregulation of radioprotective p53 target genes is an effective strategy for addressing the gastrointestinal syndrome. Mol Cancer Ther; 17(2); 432–42. ©2017 AACR. See all articles in this MCT Focus section, “Developmental Therapeutics in Radiation Oncology.”

1 August 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Akinori MoritaAkinori Morita
Akinori Morita
SAShinya Ariyasu
Shinya Ariyasu
BWBing Wang
Bing Wang
TATetsuo Asanuma
Tetsuo Asanuma
TOTakayoshi Onoda
Takayoshi Onoda
SAShin Aoki
Shin Aoki

26 September 2021 in Genes
Verified
Journal Article
Open access
PDF file
YNYuichi Nishiyama
Yuichi Nishiyama
Akinori MoritaAkinori Morita
Akinori Morita
STShogo Tatsuta
Shogo Tatsuta
MKMisaki Kanamaru
Misaki Kanamaru
SMSakaue Masahiro
Sakaue Masahiro
TSTakeshi Sugai
Takeshi Sugai
Flavonoids are a subclass of polyphenols which are attractive, due to possessing various physiological activities, including a radioprotective effect. Tumor suppressor p53 is a primary regulator in the radiation response and is involved in the pathogenesis of radiation injuries. In this study, we revealed that isorhamnetin inhibited radiation cell death, and investigated its action mechanism focusing on DNA damage response. Although isorhamnetin moderated p53 activity, it promoted phosphorylation of ataxia telangiectasia mutated (ATM) and enhanced 53BP1 recruitment in irradiated cells. The radioprotective effect of isorhamnetin was not observed in the presence of ATM inhibitor, indicating that its protective effect was dependent on ATM. Furthermore, isorhamnetin-treated mice survived gastrointestinal death caused by a lethal dose of abdominal irradiation. These findings suggested that isorhamnetin enhances the ATM-dependent DNA repair process, which is presumably associated with the suppressive effect against GI syndrome.

1 January 2017 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
TKTakanori Katsube
Takanori Katsube
Bing WangBing Wang
Bing Wang
KTKaoru Tanaka
Kaoru Tanaka
YNYasuharu Ninomiya
Yasuharu Ninomiya
GVGuillaume Varès
Guillaume Varès
MNMitsuru Nenoi
Mitsuru Nenoi